By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo ...
Cigna (CI) is ending coverage for GLP-1 weight-loss drugs such as Eli Lilly's (LLY) Zepbound and Novo Nordisk’s (NVO) Wegovy ...
Marianne Bonner, CPCU, ARM, covers business insurance topics for Investopedia, building on 30 years of experience working in the insurance industry. She has written extensively for The Risk Report, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results